This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Feb;128(3):405-6; author reply 406-7.

doi: 10.1111/j.1365-2141.2004.05338.x.

Serum free light chains for monitoring multiple myeloma

J Tate, P Mollee, D Gill

PMID: 15667546
DOI: 10.1111/j.1365-2141.2004.05338.x

Comment

Serum free light chains for monitoring multiple myeloma

J Tate et al. Br J Haematol. 2005 Feb.

. 2005 Feb;128(3):405-6; author reply 406-7.

doi: 10.1111/j.1365-2141.2004.05338.x.

Authors

J Tate, P Mollee, D Gill

PMID: 15667546
DOI: 10.1111/j.1365-2141.2004.05338.x

No abstract available

PubMed Disclaimer

Comment on

Serum free light chains for monitoring multiple myeloma.
Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR. Mead GP, et al. Br J Haematol. 2004 Aug;126(3):348-54. doi: 10.1111/j.1365-2141.2004.05045.x. Br J Haematol. 2004. PMID: 15257706

Similar articles

Serum free light chains for monitoring multiple myeloma.
Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR. Mead GP, et al. Br J Haematol. 2004 Aug;126(3):348-54. doi: 10.1111/j.1365-2141.2004.05045.x. Br J Haematol. 2004. PMID: 15257706
The evolving use of serum free light chain assays in haematology.
Pratt G. Pratt G. Br J Haematol. 2008 May;141(4):413-22. doi: 10.1111/j.1365-2141.2008.07079.x. Epub 2008 Mar 3. Br J Haematol. 2008. PMID: 18318757 Review.
[Clinical value of the blood measurement of the free light chains of immunoglobulins].
Bidet A, Marit G, Bérard AM. Bidet A, et al. Ann Biol Clin (Paris). 2008 Jul-Aug;66(4):427-31. doi: 10.1684/abc.2008.0250. Ann Biol Clin (Paris). 2008. PMID: 18725344 French.
Renal impairment in multiple myeloma: time is of the essence.
Hutchison CA, Bridoux F. Hutchison CA, et al. J Clin Oncol. 2011 Apr 10;29(11):e312-3; author reply e314. doi: 10.1200/JCO.2010.34.3038. Epub 2011 Feb 22. J Clin Oncol. 2011. PMID: 21343553 No abstract available.
[Progress in the management of multiple myeloma introduced by serum free light chain measurement].
Shimazaki C. Shimazaki C. Rinsho Ketsueki. 2010 Oct;51(10):1491-8. Rinsho Ketsueki. 2010. PMID: 20962483 Review. Japanese. No abstract available.

See all similar articles

Cited by

[Evaluation and comparison of prognostic value of serum free light chain ratio/difference in patients with newly diagnosed multiple myeloma].
Li L, Jiang H, Fu WJ, Du J, He HY, Lu J, An R, He J, Zhang H, Zhao YY, Wu H, Hou J. Li L, et al. Zhonghua Xue Ye Xue Za Zhi. 2019 Apr 14;40(4):321-326. doi: 10.3760/cma.j.issn.0253-2727.2019.04.011. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31104445 Free PMC article. Chinese.
Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies.
Davern S, Tang LX, Williams TK, Macy SD, Wall JS, Weiss DT, Solomon A. Davern S, et al. Am J Clin Pathol. 2008 Nov;130(5):702-11. doi: 10.1309/AJCPNS6K1CYJPDBA. Am J Clin Pathol. 2008. PMID: 18854262 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information